Marc H. Scheetz, Pharm.D., MSc, BCPS-AQID


Dr. Marc Scheetz

Midwestern University Chicago College of Pharmacy 

555 31st Street
Alumni Hall, 381
Downers Grove, IL 60515  

Infectious Diseases Pharmacist
Northwestern Memorial Hospital
251 E. Huron St.
Feinberg Pavilion, LC 700
Chicago, IL 60611



Marc Scheetz attained a Doctorate of Pharmacy from Butler University, earned a Masters of Science in Clinical Investigation degree at Northwestern University, and completed his pharmacy practice residency and an infectious diseases fellowship at Northwestern Memorial Hospital. Dr. Scheetz is a Professor at Midwestern University in the Chicago College of Pharmacy and holds a joint appointment in the Department of Pharmacology, College of Graduate Studies.  Dr. Scheetz is the Director of the Pharmacometric Center of Excellence at Midwestern University.  He currently practices clinically as an infectious diseases pharmacist at Northwestern Memorial Hospital in downtown Chicago, IL and serves as the Director for the Post-Doctoral Fellowship Program in Infectious Diseases Pharmacotherapy.

Dr. Scheetz has authored a number of original research manuscripts and review articles in the area of anti-infective pharmacokinetics and pharmacodynamics and currently serves as a reviewer for several infectious diseases, pharmacy, and medical journals. His primary research interest lies in the interface of the pharmacokinetic/pharmacodynamic interaction (i.e. between antimicrobials, pathogens, and hosts). He is particularly interested in assessing modifiable pharmacologic variables in the treatment of infectious diseases and identifying optimal exposures against the backdrop of toxicity.  His group studies toxicology in the laboratory as well as through clinical data modeling.  Dr. Scheetz is actively engaged in local and national leadership positions and formerly served as a member of the FDA Antimicrobial Drugs Advisory Committee.

Select Publications (out of >110  peer reviewed manuscripts)

  1. Scheetz MH, Crew PE, Miglis C, Gilbert EM, Sutton SH, O'Donnell JN, Postelnick M, Zembower T, Rhodes NJ. Investigating the Extremes of Antibiotic Use with an Epidemiologic Framework. Antimicrob Agents Chemother. 2016;60(6):3265-9. doi: 10.1128/AAC.00572-16. PubMed PMID: 27001807; PMCID: 4879355.
  2. Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH. Evaluation of vancomycin exposures associated with elevations in novel urinary biomarkers of acute kidney injury in vancomycin-treated rats. Antimicrob Agents Chemother. 2016. doi: 10.1128/AAC.00591-16. PubMed PMID: 27431226.
  3. O'Donnell JN, Venkatesan N, Manek M, Rhodes NJ, Scheetz MH. Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations. Am J Health Syst Pharm. 2016;73(4):241-6. doi: 10.2146/ajhp150170. PubMed PMID: 26843502.
  4. O'Donnell JN, O'Donnell EP, Kumar EJ, Lavhale MS, Andurkar SV, Gulati A, Scheetz MH. Pharmacokinetics of centhaquin citrate in a dog model. J Pharm Pharmacol. 2016;68(6):803-9. doi: 10.1111/jphp.12554. PubMed PMID: 27109141.
  5. Rhodes NJ, O'Donnell JN, Lizza BD, McLaughlin MM, Esterly JS, Scheetz MH. Tree-Based Models for Predicting Mortality in Gram-Negative Bacteremia: Avoid Putting the CART before the Horse. Antimicrob Agents Chemother. 2015;60(2):838-44. Epub 2015/11/26. doi: 10.1128/aac.01564-15. PubMed PMID: 26596934; PMCID: PMC4750664.
  6. Rhodes NJ, Kuti JL, Nicolau DP, Van Wart S, Nicasio AM, Liu J, Lee BJ, Neely MN, Scheetz MH. Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival. Antimicrob Agents Chemother. 2015;60(3):1401-10. Epub 2015/12/17. doi: 10.1128/aac.01956-15. PubMed PMID: 26666929.
  7. Rhodes NJ, Gardiner BJ, Neely MN, Grayson ML, Ellis AG, Lawrentschuk N, Frauman AG, Maxwell KM, Zembower TR, Scheetz MH. Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis. J Antimicrob Chemother. 2015;70(7):2068-73. Epub 2015/03/25. doi: 10.1093/jac/dkv067. PubMed PMID: 25802286.
  8. Rhodes NJ, MacVane SH, Kuti JL, Scheetz MH. Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes. Clin Infect Dis. 2014;59(6):905-7. Epub 2014/05/29. doi: 10.1093/cid/ciu402. PubMed PMID: 24867788.
  9. McLaughlin MM, Advincula MR, Malczynski M, Barajas G, Qi C, Scheetz MH. Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonella model and a pilot study to translate to patient outcomes. BMC infectious diseases. 2014;14:31. Epub 2014/01/17. doi: 10.1186/1471-2334-14-31. PubMed PMID: 24428847; PMCID: PMC3897888.
  10. Scheetz MH, Bolon MK, Esterly JS, Reddy P, Postelnick M, Lee TA. Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model. Pharmacotherapy. 2011;31(5):469-79. Epub 2011/09/20. doi: 10.1592/phco.31.5.469. PubMed PMID: 21923428.
  11. Esterly JS, Griffith M, Qi C, Malczynski M, Postelnick MJ, Scheetz MH. Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections. Antimicrob Agents Chemother. 2011;55(10):4844-9. Epub 2011/08/10. doi: 10.1128/aac.01728-10. PubMed PMID: 21825287; PMCID: PMC3186964.
  12. Scheetz MH, Knechtel SA, Malczynski M, Postelnick MJ, Qi C. Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption. Antimicrob Agents Chemother. 2008;52(6):2256-9. doi: 10.1128/AAC.00070-08. PubMed PMID: 18391028; PMCID: 2415807.
  13. Scheetz MH, Wunderink RG, Postelnick MJ, Noskin GA. Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia. Pharmacotherapy. 2006;26(4):539-50. doi: 10.1592/phco.26.4.539. PubMed PMID: 16553514.
  14. Rhodes NJ, Wagner JL, Gilbert EM, Crew PE, Davis SL, Scheetz MH. Days of Therapy and Antimicrobial Days: Similarities and Differences Between Consumption Metrics. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. 2016;37(8):971-3. doi: 10.1017/ice.2016.109. PubMed PMID: 27174570.
  15. McLaughlin M, Advincula MR, Malczynski M, Qi C, Bolon M, Scheetz MH. Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae. Antimicrob Agents Chemother. 2013;57(10):5131-3. Epub 2013/07/10. doi: 10.1128/aac.00607-13. PubMed PMID: 23836188; PMCID: PMC3811461.

Other Websites:

Fellowship Information, Recruiting One Fellow Per Year starting July 2014

Current Fellow Pages

Antimicrobial Stewardship Website (Northwestern Memorial Hospital)

Disclaimer: Any information contained here is not intended as a substitute for professional medical advice, emergency treatment or formal training. Don't use this information to diagnose or develop a treatment plan for a health problem or disease without consulting a qualified health care provider. If you're in a life-threatening or emergency medical situation, seek medical assistance immediately. Moreover, the site is not intended to be, and you understand and agree that it does not constitute, the provision or practice of medical, nursing, or professional health care advice or services in any jurisdiction.